Clinical application · Document 09

The Veteran Mental Health and Resilience Restoration Protocol

Nutraceutical Assisted Programs

A Reference Protocol of the NAP Standards Library Veteran Health Specialty · Protocol VH-01 The First Published Exemplar of a Complete NAP Protocol Michael Andrew Feller Jones Founder, Nutraceutical Assisted Programs Category

About This Protocol

This is the first complete protocol published to the NAP Standards Library, and it is offered as the reference exemplar of what every NAP protocol looks like: a forensic assessment, a terrain-first phased restoration sequence, condition-specific intervention, somatic and spiritual integration, community reintegration, defined outcome measurement, and explicit safety governance — all interoperating with conventional care.

It is written at the standards level. It specifies the clinical logic, the sequence, the intervention classes, the clinical targets, the outcome instruments, and the safety rules. It does not specify proprietary formulations or fixed doses. Agent selection, dosing, and titration are individualized by the credentialed NAP practitioner for the specific patient, within the safety boundaries defined here. This is a clinical framework, not a prescription, and not medical advice.

It is also a mental health protocol for a population at elevated risk of suicide. Crisis safety governs everything that follows. A veteran in crisis is stabilized first; restoration proceeds second.

Veterans Crisis Line: dial 988, then press 1 · text 838255 · VeteransCrisisLine.net

PART I. SCOPE AND PRINCIPLES

1. Clinical Scope and Indication

This protocol is organized around a working hypothesis — not an established finding — that these conditions (post-traumatic stress, depression, anxiety, suicidal ideation, the cognitive and mood sequelae of traumatic brain injury, substance use disorder, sleep collapse, and chronic pain) frequently co-occur in veterans and may share contributing biological factors. The integrated cascade model has not been validated, and each condition retains its own first-line evidence-based treatment.

It is indicated for veterans and active service members presenting with one or more of these conditions, particularly where conventional pharmaceutical management has produced incomplete or non-durable results. It is designed to be delivered alongside VA, military, and community mental health care, never as a replacement for it, and to be compatible with the self-care aims of the VA Whole Health model and to document toxic-exposure history relevant to a veteran's PACT Act claim. It has not been reviewed, approved, or endorsed by the Department of Veterans Affairs, and no affiliation with VA is claimed or implied.

It is not a stand-alone treatment for acute psychiatric emergency. Active suicidal crisis, acute psychosis, acute intoxication or withdrawal, and acute medical instability are stabilized through emergency and conventional channels first.

2. Foundational Principles

This protocol operationalizes the principles of the NAP Manifesto in a single population.

Terrain before intervention. The biological substrate is assessed and restored before, and underneath, symptom-directed work.
Cascade-aware sequencing. The framework organizes care around five domains — toxic exposure, gastrointestinal function, nutritional status, endocrine function, and medication burden reviewed with the prescriber. The ordering reflects the framework's clinical reasoning and has not been compared to alternative sequences in any trial.
Natural first, pharmaceutical when necessary. Pharmaceuticals remain available and appropriate; de-prescribing, where indicated, is gradual and supervised.
The patient is a system. Body, brain, spirit, family, and community are treated as one.
Function over perfection. Progress is measured by restored capacity, not by the elimination of every symptom.

PART II. SAFETY AND ASSESSMENT

3. Phase Zero — Crisis Safety and Medical Baseline

No restorative work begins until Phase Zero is complete.

Crisis and suicide-risk screening. Every patient is screened at intake and at defined intervals with a validated suicide-risk instrument (for example, the Columbia Suicide Severity Rating Scale). Any active risk triggers the crisis pathway: the Veterans Crisis Line, coordination with the patient's mental health provider, a safety plan, and emergency referral where indicated. Restoration is paused, not abandoned, during acute crisis.

Medical baseline and contraindication screening. A complete current medication list, medical and psychiatric history, pregnancy status where applicable, and hepatic, renal, cardiac, and metabolic status are established before any intervention. Conditions that modify or contraindicate specific interventions are flagged here.

Coordination of care. The patient's existing prescribers are identified and, with consent, engaged. This protocol is delivered in coordination with conventional care, and any future de-prescribing is theirs to authorize and supervise.

Absolute safety rules. (1) No psychiatric or other medication is reduced or discontinued without the supervising prescriber's authorization. (2) No toxic-burden mobilization is undertaken before drainage capacity and microbial and barrier integrity are established (see Phase Four). (3) No intervention proceeds against a known contraindication. (4) Crisis stabilization always supersedes the restoration sequence.

4. Assessment — The Five-Component Veteran Assessment Protocol

Assessment follows the standardized Veteran Assessment Protocol of the Specialty Track, completed across the first two to four encounters:

Exposure history — the cumulative environmental and service exposure timeline.
Symptom and functional history — the temporal progression of the presentation, mapped against exposures and pharmaceutical initiation.
Pharmaceutical burden inventory — every medication, current and historical, to inform later supervised de-prescribing.
Biomarker panel — toxic burden, microbial and barrier markers, comprehensive mineral and nutrient status, essential fatty acid status (omega-3 index), inflammatory markers, full hormonal panel, and standard metabolic, hepatic, renal, and lipid chemistry.
Functional and psychological assessment — validated instruments establishing the functional baseline: PCL-5 (post-traumatic stress), PHQ-9 (depression), GAD-7 (anxiety), a cognitive screen where TBI is present, AUDIT or DAST for substance use, and sleep, pain, quality-of-life, purpose, and community-engagement measures.

These five components integrate into a single map of the individual's cascade, which sequences everything that follows.

PART III. THE PHASED RESTORATION SEQUENCE

The restoration sequence is the heart of the protocol. Each phase has an objective, defined clinical targets, intervention classes, safety boundaries, and tracked outcomes. The phases overlap rather than occur in strict isolation, and the sequence is governed by one principle: the body is made safe and resourced before it is asked to release burden or process trauma. Agent selection and dosing within each class are individualized by the credentialed practitioner.

5. Phase One — Create Safety and Calm the Nervous System

Cornerstones One and Three. Objective: shift the veteran out of chronic sympathetic activation and restore the sleep on which all repair depends.

Clinical targets: autonomic regulation, sleep architecture, acute anxiety load.
Intervention classes: circadian and sleep-hygiene restructuring; breathwork and parasympathetic-activating somatic practice from Cornerstone Three; magnesium and glycine, which may support sleep; and calming botanicals selected to patient presentation and used symptomatically.
Safety: screen for interactions with sedating medications; coordinate with any prescribed sleep agents.
Tracked: sleep quality and duration, GAD-7, subjective regulation.

6. Phase Two — Replenish the Foundational Substrate

Cornerstone One. Objective: restore the raw materials the brain and nervous system are built from and run on. Response to repletion varies and has not been characterized in this population.

Clinical targets: mineral status (magnesium, zinc, selenium, iodine) interpreted against established laboratory reference ranges; essential fatty acid status by omega-3 index; B-vitamin complex; vitamin D.
Intervention classes: bioavailable mineral repletion with attention to antagonist pairs; clinical-grade EPA and DHA repletion (third-party tested for purity and freshness); methylated B-vitamins where indicated; vitamin D restoration.
Rationale and calibration: essential fatty acid status is a structural substrate of the brain, and low DHA status has been associated with elevated suicide risk in active-duty service members (an association, not proof of causation; see the Evidence Compendium). Repletion is foundational substrate restoration, not a stand-alone antidepressant claim.
Tracked: serial mineral and omega-3 index testing; PHQ-9; energy and cognition.

7. Phase Three — Repair the Gut and Restore the Barrier

Cornerstone One. Objective: support gastrointestinal function and nutrient absorption. A working hypothesis of this framework is that intestinal barrier dysfunction may contribute to systemic inflammation; this has not been shown to change brain inflammatory load in humans.

Clinical targets: microbial balance, intestinal barrier integrity, where indicated parasitic and fungal clearance.
Intervention classes: where a parasitic or bacterial infection is clinically suspected, the patient is referred to a physician for evaluation and standard treatment; this protocol does not treat infections. Nutritional support: targeted probiotics, prebiotic and fermented foods, and dietary modification.
Safety: any new or worsening symptom during this phase is treated as a possible adverse reaction rather than a sign of progress; the intervention is stopped and the patient's physician consulted.
Tracked: digestive symptoms; inflammatory markers where indicated; mood and cognitive scores tracked as outcomes, without attributing change to a specific mechanism.

8. Phase Four — Reduce Toxic Burden

Cornerstone One. Objective: document the veteran's exposure history, reduce ongoing exposures where identified, and support normal hepatic and renal elimination. This protocol makes no claim to reduce accumulated body burden.

The cardinal safety rule: this protocol does not attempt to mobilize, bind, or chelate stored metals. Chelation for confirmed metal poisoning is a physician-directed treatment and is outside the scope of this protocol. Mobilization is paired with binding and with microbial clearance, not run in isolation.
Intervention classes: support for normal hepatic and renal function through hydration, adequate protein and fiber, and reducing ongoing exposure. This protocol does not attempt to mobilize or chelate stored metals.
Safety: contraindicated or modified in pregnancy, significant renal or hepatic impairment, and other flagged conditions; any new or worsening symptom is reviewed with the patient's physician.
Tracked: serial toxic-burden testing, symptom response, tolerance.

9. Phase Five — Restore Cellular Energy

Cornerstones One and Two. Objective: address fatigue and exercise intolerance where present, through graded activity, sleep, and correction of documented nutrient deficiencies. This protocol does not claim to restore mitochondrial function or metabolic flexibility, neither of which is measured here.

Clinical targets: mitochondrial function, oxidative-stress load, metabolic flexibility.
Intervention classes: mitochondrial cofactor support; oxidative-stress reduction; graded movement and recovery; dietary pattern toward metabolic flexibility.
Tracked: energy, exercise tolerance, metabolic markers.

10. Phase Six — Restore Hormonal and Metabolic Function

Cornerstones One and Two. Objective: identify endocrine dysfunction through appropriate testing and refer for treatment where indicated. Whether earlier phases improve endocrine function has not been studied and should not be assumed.

Clinical targets: HPA-axis and cortisol rhythm, thyroid, sex hormones, insulin and metabolic markers.
Intervention classes: cofactor optimization; sleep and resistance training, which support endogenous hormone production; botanical support used symptomatically only, as no botanical has been shown to correct a specific endocrine axis. Where hormone therapy is clinically indicated, it is prescribed and monitored by a qualified physician.
Rationale: sleep is addressed first for its own well-established benefits. Whether restoring or extending sleep raises testosterone has not been established, and this phase does not rely on such an effect.
Tracked: serial hormonal panels; mood, drive, body composition.

11. Phase Seven — Restore the Brain and Process the Trauma

Cornerstones Two and Three. Objective: with the substrate now restored, support neurological regeneration and undertake the trauma-processing work that could not consolidate on a collapsing terrain.

Clinical targets: neuroinflammation, neuroregeneration and neuroplasticity, neurotransmitter substrate, the trauma itself.
Intervention classes: general nutritional support for brain health, with no claim that any botanical improves cognition, protects neurons, or treats the cognitive effects of traumatic brain injury; the structured somatic and trauma-resolution modalities of Cornerstone Three (breathwork, meditation and yoga nidra, sound and vibrational practice, structured emotional processing); and, only in the limited settings where it is currently lawful, the wraparound preparation and integration support around psychedelic-assisted therapy — this protocol supplies readiness and safety screening, not the therapy itself. This ordering reflects clinical convention within the framework rather than evidence of superiority; no trial has compared sequencing. Trauma-focused therapy is not deferred by this protocol and may begin or continue at any phase.
Tracked: PCL-5, cognitive measures, durability of gains.

12. Phase Eight — Reintegration, Purpose, and Community

Cornerstone Four. Objective: rebuild belonging, mission, and meaning. Social isolation is associated with worse health outcomes, which is why reintegration is treated as a clinical priority — though loss of purpose is not itself a diagnosis, and it is not established that biological gains reverse without it.

Intervention classes (prescribed, tracked): structured peer community; mentorship; service projects; intergenerational engagement; purpose-discovery work; spiritual community honoring the patient's tradition or supporting its discovery; and family-system repair, recognizing that the family served too.
Tracked: purpose, community-engagement, and quality-of-life measures alongside the biomedical outcomes.

PART IV. ADAPTATION, INTEGRATION, AND OUTCOMES

13. Condition-Specific Layers

The phased sequence is the shared spine. The dominant presentation tunes the emphasis, not the foundation:

Post-traumatic stress: heavier investment in Phase One regulation and Phase Seven somatic and trauma processing.
Depression and suicidality: first-line care is the patient's VA or community mental health treatment, including safety planning, evidence-based psychotherapy, and medication as prescribed. This protocol contributes adjunctive sleep and nutritional support only, never substituting for or delaying that care, with continuous crisis monitoring throughout.
Traumatic brain injury: emphasis on Phase Five energy and Phase Seven neuroregeneration and neuroinflammation.
Substance use disorder: this protocol is adjunctive only and never a substitute for established addiction treatment, which remains first-line. Nutritional and sleep support may aid general recovery; they do not treat the disorder.

14. Integration with Conventional Care and Supervised De-Prescribing

This protocol interoperates with VA, military, and community care. Where the pharmaceutical burden inventory and restoration progress indicate, de-prescribing is gradual, monitored, and authorized and supervised by the prescribing clinician — never abrupt, never unilateral, and always with supportive substrate in place. This protocol does not aim to reduce or discontinue any medication. Medication decisions belong solely to the prescribing clinician, and patients should not adjust or stop a psychiatric medication based on how they feel during this protocol.

15. Outcome Measurement

Outcomes are tracked on a defined schedule and reported in functional terms.

Validated instruments re-administered at set intervals: PCL-5, PHQ-9, GAD-7, the suicide-risk instrument, and sleep, pain, and quality-of-life measures.
Biomarkers re-tested to confirm restoration: mineral status, omega-3 index, inflammatory markers, hormonal and metabolic panels, and toxic-burden markers.
Functional milestones: sleep restored, energy returned, drive and cognition recovered, relationships and purpose re-engaged.
Definition of response: restored capacity to live, work, connect, and find meaning — function over the elimination of every symptom.

Outcome data, de-identified and consented, feeds the NAP outcome registry, where it refines this protocol and builds the evidence base the framework calls for.

PART V. EVIDENCE AND SAFETY

16. Evidence Basis and Calibration

Individual mechanisms are cited and graded in the NAP Evidence Compendium using an explicit strength hierarchy. Where a component rests on mechanistic rationale or preclinical data alone, the Compendium says so; not every element of this protocol has human clinical evidence. What is not yet proven — and what this protocol states plainly — is the integrated cascade as a unified clinical hypothesis and the comparative effectiveness of this comprehensive sequence against single-intervention care. Those are precisely the questions the NAP outcome registry exists to answer. This protocol is therefore offered as a structured, evidence-informed, falsifiable clinical model, not as a closed finding. The essential fatty acid and suicide-risk relationship is presented as the retrospective case-control association the evidence supports, not as a causal or prevalence claim.

17. Safety, Contraindications, and Scope of Practice

This protocol is delivered only by a credentialed NAP practitioner holding the Veteran Health Specialty, working within scope and in coordination with the patient's medical and mental health providers.
Crisis stabilization supersedes restoration at every point.
Toxic-burden mobilization follows the cardinal safety rule (Phase Four) without exception.
De-prescribing is prescriber-authorized and supervised.
Specific contraindications — pregnancy and lactation, significant renal or hepatic impairment, drug–nutrient and drug–botanical interactions, and others surfaced at medical baseline — modify or exclude specific interventions.
Agent selection and dosing are individualized by the practitioner; this document defines structure and boundaries, not prescriptions.

CLOSING

This is what a NAP protocol looks like: forensic before it is therapeutic, sequenced before it is aggressive, measured before it is declared successful, and safe before it is anything at all. It treats the veteran's mental health crisis as the biological and human event it is — and it restores, in order, the terrain, the brain, and the life.

It is the first protocol of the NAP Standards Library. Others, across every clinical territory and every population, follow this same shape.

Veterans Crisis Line: dial 988, then press 1 · text 838255 · VeteransCrisisLine.net

Suggest a change to this document Become a contributor